KR101837960B1 - Anti-wrinkle composition comprising extracts of nelumbo nucifera roots, and willow or propolis - Google Patents
Anti-wrinkle composition comprising extracts of nelumbo nucifera roots, and willow or propolis Download PDFInfo
- Publication number
- KR101837960B1 KR101837960B1 KR1020150132382A KR20150132382A KR101837960B1 KR 101837960 B1 KR101837960 B1 KR 101837960B1 KR 1020150132382 A KR1020150132382 A KR 1020150132382A KR 20150132382 A KR20150132382 A KR 20150132382A KR 101837960 B1 KR101837960 B1 KR 101837960B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- propolis
- willow
- lotus root
- composition
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to a wrinkle-improving composition containing a lotus root extract and a willow extract or propolis, wherein the lotus root extract; And at least one selected from willow extract and propolis extract as an active ingredient. The synergistic action of the effective ingredient maximizes the effect of pro-collagen synthesis and / or elastase inhibition, and ultimately, Can be improved.
Description
The present invention relates to a wrinkle-removing composition containing a lotus root extract and a willow extract or propolis.
The human skin undergoes changes due to various internal and external factors as it gets older. In other words, internally, secretion of various hormones that regulate metabolism is reduced, the function of immune cells and the activity of cells are lowered, and the biosynthesis of immune proteins and biocompatible proteins necessary for the living body is reduced, and ozone layer destruction Increase of ultraviolet ray reaching the surface and environmental pollution are further intensified, and free radicals and active noxious oxygen are generated so that wrinkles are increased, elasticity is decreased, and the number of spots, freckles and black blotches is increased. .
However, because modern society attaches importance to youth and beauty, it wants to delay the aging of the skin caused by internal or external factors, or to restore the aging that has already progressed, in order to improve the quality of life. Therefore, various wrinkle improving agents, elasticity improving agents, whitening agents, and the like are being developed.
As the aging progresses, the content and arrangement of collagen, elastin, hyaluronic acid, proteoglycans, glycosaminoglycan, fibronectin and glycoprotein, which are constituents of the skin, are changed or decreased and the ability to bind with water is decreased, , Skin dryness, and skin sagging. In addition, collagen is degraded due to an increase in matrix metalloproteinase (MMP), which is an enzyme that degrades skin tissue by ultraviolet rays, and biosynthesis of elastase is increased. Thus, elastin and adhesion protein It is known to decompose fibronectin to promote aging. A large amount of research has been conducted on active ingredients capable of preventing and improving such aging phenomena. Representatively, a variety of wrinkle-improving ingredients have been developed that either increase collagen or elastin, the structural proteins of the dermal layer, or prevent collagen degradation through matrix metalloprotease inhibition.
US Patent No. 5,925,348 discloses an anti-aging cosmetic composition using a seed extract of lotus flower, and Japanese Patent No. 4, 693963 contains information on promoting collagen synthesis using seed embryos of the lotus.
However, a composite composition containing a combination of willow extract or propolis with a mushroom extract is not known, and the collagen synthesis promoting effect has not yet reached a satisfactory level.
The inventors of the present invention have confirmed that a combination preparation obtained by mixing willow extract and / or propolis with a soft extract has a remarkable effect of accelerating collagen synthesis, compared with the respective preparations, and completed the present invention and provided a composition therefor do.
SUMMARY OF THE INVENTION The present invention has been made to solve the above-mentioned problems of the prior art,
Lotus root extract; And
A wrinkle-improving composition comprising at least one member selected from willow extract and propolis extract as an active ingredient.
The present invention also provides a wrinkle-improving composition characterized in that the active ingredient has a collagen synthesis promoting action and / or an elastase inhibiting action.
Further, in the present invention, the above-mentioned effective ingredient has a collagen synthesis promoting action,
The total content of the active ingredient extract is 0.5% by weight or less,
Wherein the wrinkle-reducing composition is comprised of Lotus root extract: Propolis extract: Willow extract = 0.8-1.2: 1.6-2.4: 0.8-1.2 weight ratio.
In the present invention, it is preferable that the effective ingredient has an elastase inhibiting action,
Wherein the wrinkle-reducing composition is comprised of Lotus root extract: Propolis extract: Willow extract = 1.6 to 2.4: 0.8 to 1.2: 0.8 to 1.2 weight ratio.
The present invention also provides a wrinkle-improving composition, wherein the active ingredient is contained in an amount of 5% by weight or less based on the total weight of the composition.
In addition, the composition of the present invention can be used as a cosmetic composition for cosmetics including toner, flexible lotion, convergent lotion, nutritional lotion, ampoule, lotion, essence, nutritional cream, eye cream, massage cream, cleansing cream, cleansing lotion, foaming wash, cleansing foam, , Cleansing gel, wash off pack, peel off pack, sheet mask pack, hydrogel mask pack, lipo gel mask pack, clay mask pack, soap, spray, line cream, sun lotion, Make-up base, foundation, and primer product.
INDUSTRIAL APPLICABILITY The present invention has the effect of maximizing the effect of procollagen synthesis and / or the inhibition of elastase by synergistic action between the active ingredients, and ultimately improving skin wrinkles.
Fig. 1 is a graph showing the results of the production of procollagen by concentration.
2 is a graph showing cytotoxicity results by concentration.
3 is a graph showing cytotoxicity results at a concentration of 2%.
4 is a graph showing the results of inhibition of elastase at a concentration of 2%.
Hereinafter, the present invention will be described in detail.
According to the present invention,
Lotus root extract; And
Wrinkle extract and propolis extract as an active ingredient.
The above-mentioned effective ingredient has a collagen synthesis promoting action and / or an elastase inhibiting action, and can give a wrinkle improving effect.
From the viewpoint of promoting collagen synthesis, it is preferable that the total content of the active ingredient extract is lower than 0.5% by weight (when the concentration is high, cytotoxicity is manifested and the collagen synthesis effect is also inferior). Lotus root extract: Propolis extract: = 0.8 to 1.2: 1.6 to 2.4: 0.8 to 1.2 weight ratio is preferable because it is the combination having the strongest synergistic effect. A more detailed understanding of this may be made through the following Examples and Experimental Examples.
From the viewpoint of inhibition of elastase, it is preferable that the composition contains Lotus root extract: Propolis extract: Willow tree extract = 1.6-2.4: 0.8-1.2: 0.8-1.2 by weight because it is the combination having the strongest synergy. A more detailed understanding of this may be made through the following Examples and Experimental Examples.
The active ingredient is preferably contained in an amount of 5% by weight or less based on the total weight of the composition, because cytotoxicity is expressed at a high concentration. Especially, the toxicity is remarkable as the concentration of lotus root extract is increased. A more detailed understanding of this may be made through the following Examples and Experimental Examples.
The compositions of the present invention can be made into a wide variety of cosmetic formulations and related products by incorporating into formulations or products of the compositions. Non-limiting examples thereof include toners, softening lotion, convergent lotion, nutritional lotion, ampoule, lotion, essence, nutritional cream, eye cream, massage cream, cleansing cream, cleansing lotion, foaming wash, cleansing foam, cleansing water, cleansing gel Liposome mask pack, clay mask pack, soap, spray, sun cream, sun lotion, sunbath, sun mist, bevy cream, makeup base, wash-off pack, peel-off pack, sheet-like mask pack, hydrogel mask pack, , Foundations, and primer products.
Hereinafter, the present invention will be described in more detail with reference to examples. The following examples are for the purpose of illustrating the present invention and are not intended to limit the scope of the present invention.
Example
Production of Lotus root extract
The dried root was washed with purified water, dried and sieved. Purified water and ethanol 3: 7 mixed solvent were extracted by adding about 10 times volume. A cooling condenser was installed to prevent the solvent from evaporating and was extracted by heating for 12 hours while maintaining a temperature of 60 to 80 캜. The extract was filtered with 400 mesh filter cloth, and the residue was extracted once more by the same method. The extract was cooled to room temperature and filtered through a filter paper of Wattman No. 2. The filtrate was filtered through a filter paper of Wattman No. 2 and filtered using a distillation apparatus (Buchi Rotavapor R-124, Water Bath B-480 Made in Switzerland, Eyela A-3S Tokyo rikakikai) The mixture was distilled while maintaining the temperature at 80 DEG C, and the solvent was evaporated. The solvent was concentrated under reduced pressure, and then lyophilized to obtain an extract powder of the dried root.
Production of willow extract
The freeze-dried powder was obtained through the same procedure as in Example 1 except that the willow skin was used.
Preparation of propolis extract
Propolis powder was washed thoroughly with water, and the propolis powder was prepared by passing propolis powder through the filter after extracting the propolis by stirring the cornstarch and the cut propolis raw material in a stirrer.
The extracted extracts were mixed at the mixing ratios shown in Tables 1 and 2 to prepare extract bases having various mixing ratios.
extract
extract
The prepared extract base was mixed with the prescribed excipients as shown in Tables 3 and 4 to finally prepare a cosmetic composition.
Example 1
Example 2
Experimental Example
The prepared extract base was subjected to evaluation of the effect of pro-collagen formation and cytotoxicity, elastase inhibitory effect and cytotoxicity evaluation by the following concentrations.
Concentration of procollagen production by concentration
Collagen is synthesized in the cell as procollagen, secreted extracellularly and polymerized into collagen fibers. At this time, since the N-terminal and C-terminal propeptides of procollagen are released by the endopeptidase, human procollagen type I C-terminal peptide (PIP) was quantitated to confirm the amount of collagen production.
- Way:
1) A fibroblast cell (CCD-986SK) was seeded in a 48-well plate at 5 × 10 4 cells / well.
② After incubation for 24 hours, the cells were washed with PBS.
③ Sample was treated with serum-free medium.
④ cultured for 24 hours.
⑤ The culture supernatant was obtained and the amount of procollagen type I C-peptide was measured. Procollagen Type I C-peptide (PIP) Proceed according to the EIA kit method (TaKaRa MK101).
The results are shown in Table 5 and Fig.
As the concentration of Willow extract and Propolis extract increased, the amount of collagen synthesis increased. Especially, when the extracts were treated with 0.1% of each extract, the highest promoting effect of collagen synthesis was shown at 1: 2: 1 ratio of lotus root extract: propolis extract: willow extract.
Evaluation of cytotoxicity by concentration MTT assay
Living cells convert MTT (3- [4,5-dimethylthiazol-2-yl] -2,5-dipheny-Ltertrazolium bromide) into a bule formazon product by the action of the dehydrogenase in mitochondria, The product was eluted with a solvent, and the relative growth of living cells was measured by measuring the absorbance at 540 nm using ELISA. The specific confirmation method was as follows.
- checking way:
1) RAW264.7 cells were adjusted to 1.0 × 10 5 cells / ml using DMEM medium, and then inoculated into 48-well plates and cultured for 18 hours.
(2) A new medium containing the test substance and LPS (1 μg / ml) was treated at the same time and cultured for 24 hours.
③ 100 ㎕ of MTT solution (2 ㎎ / ㎖) was added and reacted at 37 ℃ for 2-4 hours.
④ Remove the medium and dissolve 300 ~ 500 μl of DMSO crystals.
⑤ Absorbance was measured at 540 nm.
The results were as shown in Tables 6 to 7 and Figs. 2 to 3 below.
In the case of lotus root extract, the collagen synthesis promoting effect was shown, but it was toxic as the concentration increased. However, it is considered that the concentration of the lotus root extract is preferably 5% or less, more preferably 4% or less, since it does not show toxicity at about 2.0%.
Elastase Inhibitory effect experiment
Elastase, known as an elastin degrading enzyme, is known as an enzyme that catalyzes the cleavage of fused bonds by breaking down elastin, an elastic fiber protein, to break the network of the dermal tissue of the skin. Therefore, it is considered that skin aging can be suppressed by lowering the elastase activity, and the effect of inhibiting the elastase activity can be confirmed and the skin wrinkle improving effect of the extract can be confirmed. The amount of p-nitroanilide produced by using N-succinyl-Ala-Ala-p-nitroanilide (Sigma) as a substrate was measured.
- Way:
① Add 100 μl of each extract to a 96-well plate at a concentration of 2.0%.
② Add 60 μl of 0.2 M Tris buffer (pH 8.0).
③ 20 μl of 5 mM N-Succinyl-Ala-Ala-p-nitroanilide as a substrate was added.
④ 20 μl of enzyme, 10 μg / ml elastase, was added.
(5) The reaction was carried out at 25 ° C for 15 minutes.
⑥ The amount of p-nitroaniline produced at 410 nm was measured.
* Positive control: Vitamine C 0.5%
The results were as shown in Table 8 and Fig.
In the evaluation of inhibition of elastase activity, lotus root extract showed the highest inhibitory effect on elastase activity. In particular, promoter of collagen synthesis was promoted at the ratio of 2: 1: 1 of lotus root extract: propolis extract: willow tree extract .
Claims (6)
Which contains at least one selected from willow extract and propolis extract as an active ingredient Wherein the effective ingredient is at least one selected from the group consisting of
(a) Lotus root extract: Propolis extract = 1.6 ~ 2.4: 0.8 ~ 1.2 weight ratio;
(b) Lotus root extract: Willow extract = 1.6 ~ 2.4: 0.8 ~ 1.2 weight ratio; or
(c) Lotus root extract: Propolis extract: Willow extract = 1.6 to 2.4: 0.8 to 1.2: 0.8 to 1.2 weight ratio,
Wherein the active ingredient has an elastase inhibitory action,
Wherein the active ingredient is present in an amount of more than 0% by weight and not more than 5% by weight based on the total weight of the composition.
Cleansing Lotion, Foaming Wash, Cleansing Foam, Cleansing Water, Cleansing Gel, Wash-off Pack, Peel-off, Lotion, Lotion, Essence, Nourishing Cream, Eye Cream, Massage Cream Such as a pack, a sheet-like mask pack, a hydrogel mask pack, a liposcel mask pack, a clay mask pack, a soap, a spray, a line cream, a sun lotion, a sunbath, a sun mist, a babe cream, a makeup base, ≪ RTI ID = 0.0 > cosmetic < / RTI > composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150132382A KR101837960B1 (en) | 2015-09-18 | 2015-09-18 | Anti-wrinkle composition comprising extracts of nelumbo nucifera roots, and willow or propolis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150132382A KR101837960B1 (en) | 2015-09-18 | 2015-09-18 | Anti-wrinkle composition comprising extracts of nelumbo nucifera roots, and willow or propolis |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170034112A KR20170034112A (en) | 2017-03-28 |
KR101837960B1 true KR101837960B1 (en) | 2018-03-13 |
Family
ID=58495797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150132382A KR101837960B1 (en) | 2015-09-18 | 2015-09-18 | Anti-wrinkle composition comprising extracts of nelumbo nucifera roots, and willow or propolis |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101837960B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230119798A (en) | 2022-02-08 | 2023-08-16 | 최미경 | Cleansing foam containing jade enzyme salt |
KR20230134276A (en) | 2022-03-14 | 2023-09-21 | 최미경 | Soap composition comprising jade enzyme salt |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102561353B1 (en) * | 2019-09-24 | 2023-07-31 | 한국화학연구원 | Nanoparticles encapsulated with propolis extract, preparation method thereof and antioxidant cosmetic composition containing the same as an active ingredient |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001039822A (en) | 1999-07-28 | 2001-02-13 | Mikimoto Pharmaceut Co Ltd | Esterase inhibitor |
JP2011121920A (en) | 2009-12-14 | 2011-06-23 | Kracie Home Products Ltd | Elastase inhibitor, and cosmetic composition and pharmaceutical composition comprising the same |
KR101216113B1 (en) * | 2010-08-31 | 2012-12-27 | 서울프로폴리스 주식회사 | The solvent fractions of propolis with suitable smell for inhibiting acne and lifting wrinkles |
KR101229045B1 (en) * | 2010-04-14 | 2013-02-04 | 최찬기 | Extracting method of nelumbo nucifera flower, leaf, stem, root, seed and cosmetic composition for anti-wrinkle containing extracts thereby |
JP2014224074A (en) | 2013-05-16 | 2014-12-04 | 地方独立行政法人北海道立総合研究機構 | Elastase activity inhibitor comprising extracts of salicaceous salix plant |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5925348A (en) | 1996-02-23 | 1999-07-20 | Medical Doctor's Research Institute, Inc. | Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin |
JP4693963B2 (en) | 2000-07-12 | 2011-06-01 | 丸善製薬株式会社 | Estrogen-like agent, collagen production promoter, and fibroblast proliferating agent |
-
2015
- 2015-09-18 KR KR1020150132382A patent/KR101837960B1/en active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001039822A (en) | 1999-07-28 | 2001-02-13 | Mikimoto Pharmaceut Co Ltd | Esterase inhibitor |
JP2011121920A (en) | 2009-12-14 | 2011-06-23 | Kracie Home Products Ltd | Elastase inhibitor, and cosmetic composition and pharmaceutical composition comprising the same |
KR101229045B1 (en) * | 2010-04-14 | 2013-02-04 | 최찬기 | Extracting method of nelumbo nucifera flower, leaf, stem, root, seed and cosmetic composition for anti-wrinkle containing extracts thereby |
KR101216113B1 (en) * | 2010-08-31 | 2012-12-27 | 서울프로폴리스 주식회사 | The solvent fractions of propolis with suitable smell for inhibiting acne and lifting wrinkles |
JP2014224074A (en) | 2013-05-16 | 2014-12-04 | 地方独立行政法人北海道立総合研究機構 | Elastase activity inhibitor comprising extracts of salicaceous salix plant |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230119798A (en) | 2022-02-08 | 2023-08-16 | 최미경 | Cleansing foam containing jade enzyme salt |
KR20230134276A (en) | 2022-03-14 | 2023-09-21 | 최미경 | Soap composition comprising jade enzyme salt |
Also Published As
Publication number | Publication date |
---|---|
KR20170034112A (en) | 2017-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100888743B1 (en) | Cosmetic compositions containing extracts of Distylium racemosum for anti-oxidation, skin whitening and anti-wrinkles | |
KR20200020623A (en) | Composition for enhancing skin condition having skin regeneration and anti-inflammation effect | |
KR101869971B1 (en) | Cosmetic compositon containing natural extracts and natural mineral | |
KR101837960B1 (en) | Anti-wrinkle composition comprising extracts of nelumbo nucifera roots, and willow or propolis | |
KR101885195B1 (en) | Cosmetic Composition with Fermentative Extract of Osmanthus fragrans | |
KR20180019972A (en) | Peptide with high whitening activity, and uses thereof | |
KR101809265B1 (en) | Cosmetic composition for containing nicotinoyl peptide and fermented natural extracts | |
JP2013053108A (en) | Camellia flower extract | |
KR102123351B1 (en) | 17 Materials Of Oriental Medicine Fermented Cosmetic Composition and Method For Preparing Thereof | |
KR102040688B1 (en) | Cosmetic composition containing extract of Sea Buckthorn Fruit | |
KR101661545B1 (en) | Cosmetic composition comprising an extracts of fermented rhodiola rosea having whitening activits | |
KR20210060801A (en) | Cosmetic Compositions for Anti-aging Comprising Complex Fermented Product of Plants | |
KR20200016813A (en) | Composition for skin whitening comprising enzymatic hydrolysates of insect | |
KR101970628B1 (en) | Cosmetic Composition Containing Extracts of Blackberry and Cranberry | |
KR20200041667A (en) | A composition for improving a skin and a method of preparing the composition | |
KR20200095087A (en) | Cosmetic composition comprising enzyme-assisted extract of hizikia fusiforme or polysaccharides from the same | |
KR102405596B1 (en) | cosmetic composition comprising Milyang20 sorghum extract | |
KR102291780B1 (en) | Functional cosmetic composition for preventing skin aging and healing wounds containing natural substances and method for manufacturing the same | |
KR20160003918A (en) | Cosmetic composition for enhancing skin elasticity or improving skin wrinkle containing herb extracts | |
KR20190081627A (en) | Cosmetic composition for whitening and anti-wrinkle containing Batillus cornutus derived peptide powder | |
KR100967617B1 (en) | Antioxidation and whitening cosmetic compositions containing extract of Isodon inflexus var. canescens | |
KR20180052151A (en) | Anti-aging and anti-wrinkle of skin improving cosmetic composition comprising the extract of Sparassis crispa as an active ingredient and preparation method of the same | |
KR20180097101A (en) | A cosmetic composition for anti-aging comprising extract of coffee grounds | |
KR101984781B1 (en) | Cosmetic composition for improving whitening, wrinkle and elasticity of skin comprising persimmon byproduct extract produced by enzymatic hydrolysis and ultra high pressure homogenization as effective component | |
KR20170038234A (en) | Ginsenoside fatty acid ester compounds, preparation method thereof, and cosmetic composition comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |